We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHU icon
12901
Cohu
COHU
$2.81B
-16,846
Closed -$465K
COIN icon
12902
Coinbase
COIN
$39.2B
-136,560
Closed -$13M
COLL icon
12903
PUT
Collegium Pharmaceutical
COLL
$916M
-13,300
Closed -$271K
CORN icon
12904
Teucrium Corn Fund
CORN
$171M
-121,225
Closed -$3.46M
CPF icon
12905
Central Pacific Financial
CPF
$996M
-25,211
Closed -$611K
CPSS icon
12906
Consumer Portfolio Services
CPSS
$205M
-10,013
Closed -$122K
CRBU icon
12907
PUT
Caribou Biosciences
CRBU
$157M
-12,100
Closed -$111K
CRDL
12908
PUT
Cardiol Therapeutics
CRDL
$207M
-30,500
Closed -$47K
CRDO icon
12909
Credo Technology Group
CRDO
$48.5B
-53,715
Closed -$818K
CRESY
12910
CALL
Cresud
CRESY
$750M
-28,103
Closed -$221K
CRGY icon
12911
PUT
Crescent Energy
CRGY
$4.03B
-16,200
Closed -$281K
CRNX icon
12912
Crinetics Pharmaceuticals
CRNX
$8.99B
-49,839
Closed -$995K
CRS icon
12913
PUT
Carpenter Technology
CRS
$27.1B
-15,300
Closed -$642K
CRPT icon
12914
First Trust SkyBridge Crypto Industry and Digital Economy ETF
CRPT
$82M
-10,547
Closed -$152K
CRTO icon
12915
Criteo S.A. Ordinary Shares
CRTO
$955M
-68,875
Closed -$1.75M
CRVS icon
12916
Corvus Pharmaceuticals
CRVS
$1.25B
-404,545
Closed -$496K
CSAN icon
12917
Cosan
CSAN
$2.48B
-109,256
Closed -$2.16M
CSTE icon
12918
PUT
Caesarstone
CSTE
$119M
-18,100
Closed -$190K
CTMX icon
12919
PUT
CytomX Therapeutics
CTMX
$732M
-11,400
Closed -$30K
CTOS icon
12920
CALL
Custom Truck One Source
CTOS
$2.4B
-13,500
Closed -$113K
CTRM icon
12921
Castor Maritime
CTRM
$22.6M
-4,354
Closed -$80.6K
CUBE icon
12922
CALL
CubeSmart
CUBE
$9.34B
-5,500
Closed -$286K
CUK
12923
PUT
DELISTED
Carnival PLC
CUK
-14,600
Closed -$267K
CURE icon
12924
Direxion Daily Healthcare Bull 3X ETF
CURE
$187M
-3,488
Closed -$393K
CURV icon
12925
PUT
Torrid Holdings
CURV
$219M
-41,200
Closed -$250K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.